Response Genetics, Inc
RGDXQ · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.02 | 0.24 | 0.76 |
| FCF Yield | -42,227.23% | -117.39% | -18.27% | -24.13% |
| EV / EBITDA | 0.66 | -1.52 | -4.03 | -4.08 |
| Quality | ||||
| ROIC | -49.89% | -140.65% | -59.03% | -58.34% |
| Gross Margin | 21.85% | 40.12% | 47.20% | 44.41% |
| Cash Conversion Ratio | 0.67 | 1.04 | 0.81 | 1.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -3.06% | -3.72% | -4.37% | -4.15% |
| Free Cash Flow Growth | -2.36% | -102.97% | 20.87% | -63.79% |
| Safety | ||||
| Net Debt / EBITDA | 0.67 | -0.57 | 0.86 | 1.08 |
| Interest Coverage | -62.14 | -19.57 | -86.51 | -89.21 |
| Efficiency | ||||
| Inventory Turnover | 106.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 137.40 | 111.81 | 55.62 | 62.93 |